sulbactam has been researched along with Bacterial Infections, Gram-Negative in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (20.00) | 18.2507 |
2000's | 10 (33.33) | 29.6817 |
2010's | 10 (33.33) | 24.3611 |
2020's | 4 (13.33) | 2.80 |
Authors | Studies |
---|---|
Courvalin, P; Dupêchez, M; Galimand, M; Lambert, T; Meziane-Cherif, D | 1 |
Arya, R; Goldner, BS; Shorr, AF | 1 |
Hornsey, M; Momin, MHFA; Phee, LM; Standing, JF; Wareham, DW | 1 |
Guclu, E; Karabay, O; Kaya, G; Ogutlu, A | 1 |
Aggarwal, A; Sahu, C; Thomas, KN | 1 |
Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C | 1 |
Han, CS; Kwon, TY; Lee, HJ; Nam, YS; Seo, MJ; Yang, JJ | 1 |
Inokuchi, R; Ishida, T; Maeda, J; Matsumoto, A; Nakajima, S; Yahagi, N | 1 |
Aleksandrova, IV; Borisova, LA; Chernen'kaia, TV; Kosolapov, DA; Nikitina, OV; Reĭ, SI | 1 |
John, J; Suryalatha, K; Thomas, S | 1 |
Hsueh, PR; Jean, SS; Lee, WS; Liao, CH; Sheng, WH | 1 |
Abelleira, M; Castelli, J; Etlin, A; Gerona, S; González, LS; Grecco, G; Harguindeguy, M; Iglesias, C; Leites, A; López, M; Medina, JC; Menéndez, J; Prieto, J; Rando, K; Scalone, P; Valverde, M | 1 |
Badía, M; Cassini, E; Córdova, E; Gómez, N; López Moral, L; Morganti, L; Rodríguez, C | 1 |
Chandra, A; Desai, C; Dhar, P; Dharap, S; Goel, A; Gupta, R; Hardikar, JV; Kapoor, VK; Kochhar, P; Mathur, AK; Modi, P; Narwaria, M; Ramesh, H; Ramesh, MK; Sastry, RA; Schou, M; Shah, S; Somasundaram, S; Sreevathsa, MR; Sudheer, OV; Varshney, S; Virk, S | 1 |
Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
Abuzenadah, AM; Alam, Q; Azhar, EI; Damanhouri, GA; Jabir, NR; Kamal, MA; Shakil, S; Tabrez, S | 1 |
Mitrokhin, SD | 1 |
Clark, NM; Day, LJ; Malani, PN; Pagani, FD; Singal, A | 1 |
Cherkashin, EA; Galeeva, EV; Ivanov, DV; Krapivina, IV; Sidorenko, SV; Veshutova, NS | 1 |
Akova, M | 1 |
Kuti, JL; Nicasio, AM; Nicolau, DP | 1 |
Allewelt, M; Lode, H; Lorenz, J; Ott, SR; Reimnitz, P | 1 |
Benjamin, R; Bodey, GP; Elting, LS; Estey, E; Koller, C; Narro, J; O'Brien, S | 1 |
Cheong, YM; Lim, VK | 1 |
Barefoot, L; Falagas, ME; Griffith, J; Ruthazar, R; Snydman, DR | 1 |
Hanaki, H; Nagayama, A; Nomura, S | 1 |
Cheong, YM; Chiu, C; Chow, C; Kumarasinghe, G | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Carmeli, Y; Harbarth, S; Harris, AD; Samore, MH | 1 |
Chiodo, F; De Simone, C; Delia, S; Gargiulo, M; Paoloni, M; Pastore, G; Scalise, G; Sorice, F; Tonietti, G; Zanussi, C | 1 |
4 review(s) available for sulbactam and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges.
Topics: Anti-Bacterial Agents; Cefepime; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam; Urinary Tract Infections | 2022 |
New Delhi metallo-β-lactamase (NDM-1): an update.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam | 2011 |
Sulbactam-containing beta-lactamase inhibitor combinations.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefoperazone; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam | 2008 |
The current state of multidrug-resistant gram-negative bacilli in North America.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; North America; Polymyxins; Sulbactam; Tigecycline | 2008 |
4 trial(s) available for sulbactam and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Cefoperazone-sulbactam for treatment of intra-abdominal infections: results from a randomized, parallel group study in India.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoperazone; Ceftazidime; Child; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Metronidazole; Middle Aged; Peritonitis; Sulbactam; Treatment Failure; Treatment Outcome | 2008 |
Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Moxifloxacin; Pneumonia, Aspiration; Quinolines; Radiography; Sulbactam | 2008 |
An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteria; Bacterial Infections; Cefoperazone; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Sulbactam | 1993 |
Clinical results of a multicenter study with sulbactam/ampicillin for the treatment of patients with lower respiratory and urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; beta-Lactamases; Culture Media; Drug Synergism; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Sulbactam; Urinary Tract Infections | 1991 |
22 other study(ies) available for sulbactam and Bacterial Infections, Gram-Negative
Article | Year |
---|---|
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Brachyspira; Cloning, Molecular; Diarrhea; Feces; Gram-Negative Bacterial Infections; Humans; Kinetics; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Sequence Analysis, DNA | 2008 |
Cefepime/sulbactam as an enhanced antimicrobial combination therapy for the treatment of MDR Gram-negative infections.
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Cefepime; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Monte Carlo Method; Sulbactam | 2020 |
The effect of cefoperazone sulbactam and piperacillin tazobactam on mortality in Gram-negative nosocomial infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sulbactam | 2020 |
Ralstonia mannitolilytica bacteraemia and gastroenteritis in a patient with rheumatoid arthritis: an emerging nosocomial infection.
Topics: Anti-Bacterial Agents; Arthritis, Rheumatoid; Bacteremia; Cefoperazone; Cross Infection; Diarrhea; Female; Gastroenteritis; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ralstonia; Sulbactam | 2021 |
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam | 2017 |
16S ribosomal RNA identification of Prevotella nigrescens from a case of cellulitis.
Topics: Acupuncture Therapy; Ampicillin; Ankle; Anti-Bacterial Agents; Cellulitis; Diabetes Mellitus, Type 2; Gram-Negative Bacterial Infections; Humans; Hypertension; Magnetic Resonance Imaging; Male; Microbial Sensitivity Tests; Middle Aged; Prevotella nigrescens; RNA, Ribosomal, 16S; Sulbactam; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Anaerobiospirillum succiniciproducens-induced bacteremia in a healthy man.
Topics: Ampicillin; Anaerobiospirillum; Anti-Bacterial Agents; Bacteremia; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Male; Middle Aged; RNA, Bacterial; RNA, Ribosomal, 16S; Sulbactam | 2014 |
[Pattern dynamics of bacteriemia and sepsis pathogens in ICU patients of emergency service].
Topics: Acetamides; Acinetobacter; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Candida; Candidiasis; Carbapenems; Cefoperazone; Drug Resistance, Multiple, Bacterial; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Klebsiella pneumoniae; Linezolid; Methicillin; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Sepsis; Sulbactam; Vancomycin | 2013 |
Wohlfahrtiimonas chitiniclastica-associated osteomyelitis: a rare case report.
Topics: Administration, Intravenous; Adult; Cefoperazone; Communicable Diseases, Emerging; Diabetes Complications; DNA, Bacterial; Gammaproteobacteria; Gram-Negative Bacterial Infections; Humans; India; Male; Molecular Sequence Data; Osteomyelitis; Phylogeny; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam; Tertiary Care Centers; Wounds and Injuries | 2015 |
Comparison of commonly used antimicrobial susceptibility testing methods for evaluating susceptibilities of clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilli to cefoperazone-sulbactam.
Topics: Anti-Bacterial Agents; Automation, Laboratory; beta-Lactamase Inhibitors; Cefoperazone; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Sulbactam; Taiwan | 2017 |
Impact of a Multimodal Approach in Prevention of Surgical Site Infection in Hepatic Transplant Recipients.
Topics: Administration, Cutaneous; Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Chlorhexidine; Drug Administration Schedule; Drug Therapy, Combination; Ether; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Liver Transplantation; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Surgical Wound Infection; Transplant Recipients | 2016 |
[Antimicrobial susceptibility of Gram-negative bacilli of community acquired intra-abdominal infections in a hospital at Buenos Aires, Argentina].
Topics: Abdomen; Adolescent; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Argentina; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Young Adult | 2016 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
[Sulperazone in the treatment of severe infections in patients with cancer].
Topics: Anti-Bacterial Agents; Cefoperazone; Cross Infection; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Neoplasms; Pneumonia, Bacterial; Sulbactam; Surgical Wound Infection; Urinary Tract Infections | 2003 |
Roseomonas infection associated with a left ventricular assist device.
Topics: Ampicillin; Anti-Bacterial Agents; Aortic Valve Insufficiency; Cardiomyopathies; Cefuroxime; Cross Infection; Drug Resistance; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Heart Transplantation; Heart-Assist Devices; Humans; Methylobacteriaceae; Michigan; Middle Aged; Sulbactam | 2003 |
[Resistance epidemiology of gramnegative nonfermenting pathogens of nosocomial infections in intensive care units and surgical departments].
Topics: Acinetobacter baumannii; Adolescent; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoperazone; Child; Child, Preschool; Cross Infection; Drug Resistance, Microbial; Genes, Bacterial; Gram-Negative Bacterial Infections; Humans; Infant; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Moscow; Pseudomonas aeruginosa; Sulbactam; Surgery Department, Hospital | 2006 |
In-vitro activity of cefoperazone-sulbactam combination against cefoperazone resistant clinical isolates in a Malaysian general hospital.
Topics: Cefoperazone; Cephalosporin Resistance; Cross Infection; Drug Combinations; Gram-Negative Bacterial Infections; Hospitals, General; Malaysia; Sulbactam | 1995 |
Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
Topics: Abdominal Abscess; Adult; Age Factors; Aged; Ampicillin; Anti-Bacterial Agents; Cefotetan; Cefoxitin; Cephamycins; Drug Resistance, Microbial; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Matched-Pair Analysis; Middle Aged; Multivariate Analysis; Penicillins; Pseudomonas Infections; Retrospective Studies; Risk Factors; Sex; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Treatment Outcome | 1996 |
Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections.
Topics: Ampicillin; beta-Lactamase Inhibitors; Cefoperazone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Retrospective Studies; Sulbactam; Tazobactam; Ticarcillin; Urinary Tract; Urinary Tract Infections | 1997 |
In vitro activity of cefoperazone-sulbactam: Singapore experience.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefoperazone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Singapore; Sulbactam | 1996 |
Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefmetazole; Cephalosporin Resistance; Cephamycins; Chi-Square Distribution; Clindamycin; Erythromycin; Fusobacterium; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Negative Bacterial Infections; Humans; Imipenem; Metronidazole; Middle Aged; Minocycline; Periodontal Diseases; Porphyromonas; Prevotella; Sulbactam; Thienamycins; Tooth Diseases | 2001 |
Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Middle Aged; Pseudomonas; Pseudomonas Infections; Statistics as Topic; Sulbactam | 2001 |